N/A N=2,167 Increasing COVID-19 Testing in Chicago's African American Testing Desserts
COVID-19 Pandemic
Primary: COVID-19 Testing Uptake — 2167 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=638 A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
Glabellar Lines
Primary: Percentage of Participants With a Grade 0 or 1 and a ≥ 2-grade Improvement From Baseline on the FWS According to Both Investigator and Subject Assessments of Glabellar…
N/A N=150 PrEP My Way: A Novel PrEP Delivery System to Meet the Needs of Young African Women
HIV/AIDS
Primary: PrEP Adherence — 12; 4 Participants
Phase 1 N=12 A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants
Healthy
Primary: Area Under the Plasma Concentration-time Profile From Time Zero Extrapolated to Infinite Time (AUCinf) of Tafamidis (Both Variant 12.2 mg Tafamidis Free Acid Tablet and…
Phase 1 N=7 A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
Type 1 Diabetes
Primary: Number of Participants With One or More Treatment-Emergent Adverse Event(s) (TEAEs) and Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to…
N/A N=30 Clinical Investigation of the WaveLight® EX500 Excimer Laser
Hyperopia · Hyperopic Astigmatism
Primary: Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) Within ±0.50 Diopter (D) at Refractive Stability — 98.3 percentage of eyes — p=<0.0001
Phase 2 N=12 Woodsmoke Particulate + Prednisone
Airway Inflammation
Primary: Change From Baseline to 4 Hours in Sputum Percent Neutrophils — -2.62; 5.45 percent neutrophils — p=0.24
Phase 3 N=1,608 A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults
COVID-19 Prevention
Primary: Geometric Mean Concentration of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) S Protein Binding Antibodies Measured by Enzyme-Linked Immunosorbent Assay…
Phase 2 N=58 Vaccination of High Risk Breast Cancer Patients
Breast Cancer · Breast Neoplasms
Primary: Identify a Feasible Schedule of Vaccination Relative to SoC Neoadjuvant Chemotherapy When the Chemovax Are Administered Concurrently. — 3; 2; 4; 2 Participants
Phase 3 N=32 Spasmodic Dysphonia Pain
Spasmodic Dysphonia
Primary: Pain Experienced — 2; 2; 2 score on a scale
N/A N=208 Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome
Primary: Number of Participants Administered Morphine Treatment — 29; 31 Participants — p=.60
N/A N=9 Intraoperative Evaluation of Axillary Lymphatics
Lymphedema · Surgery · Breast Cancer
Primary: Number of Cases Where Lymphatics Were Visualized by Blue Dye Versus by ICG Using the OnLume Imaging System — 5; 9 Participants
N/A N=69 Efficacy of Pain Neuroscience Education in Genito-Pelvic Pain/Penetration Disorder. A Randomized Controlled Trial.
Pain · Dysfunction Sexual
Primary: Visual Analogue Scale — 5.3; 5.8; 5.1; 3.8 score on a scale
Phase 2 N=44 Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
Idiopathic Hypersomnia · Narcolepsy Without Cataplexy
Primary: Change in Epworth Sleepiness Scale (ESS) Score — 5.0; 4.4 score on a scale
N/A N=120 Safety and Performance of a Fetal Monitoring System
Pregnancy
Primary: Fetal Heart Rate (FHR) — 140.1; 140.0 BPM